U.S. Gas Utilities Stock News

Integer Holdings (NYSE:ITGR) has begun a comprehensive review of its business and capital structure. The Board is assessing options that may include a sale, merger, or other business combination. The review follows heightened external interest in the company and involves financial and legal advisors. The process is focused on assessing ways to maximize value for existing shareholders. Integer Holdings, traded on the NYSE under the ticker ITGR, operates in the medical technology space,...

If you are wondering whether Keysight Technologies at around US$355.93 is a bargain or already pricing in a lot of optimism, the starting point is to understand what the current valuation is actually implying. The stock has shown strong recent momentum, with returns of 7.1% over 7 days, 22.2% over 30 days, 72.3% year to date, 142.9% over 1 year, 148.9% over 3 years and 156.2% over 5 years. This naturally raises questions about how much upside or risk is now baked into the price. Recent...

CleanSpark (NasdaqCM:CLSK) is accelerating a shift from pure Bitcoin mining toward hosting AI and high performance computing data centers. The company is in advanced talks with a potential investment grade hyperscaler tenant for direct data center capacity. New greenfield AI data center construction is underway in Georgia, backed by CleanSpark’s existing power portfolio. Management is publicly addressing concerns around data center power and water usage as part of this transition. For you...

Investors may be wondering if Prudential Financial at around US$100 a share still offers value, or if most of the opportunity has already been priced in. The stock last closed at US$100.27, with returns of 3.5% over the past week, 2.8% over the past month, 3.7% over the last year and 43.0% over three years. Year to date it is down 11.9% and up 21.6% over five years. Recent headlines have focused on Prudential Financial in the context of broader insurance sector sentiment and changing...

FDA approves Jakafi XR extended-release tablets for myelofibrosis, polycythemia vera and graft-versus-host disease. Jakafi XR offers a once-daily dosing option that differs from existing formulations of ruxolitinib. The approval expands Incyte's Jakafi franchise and broadens its treatment toolkit across several serious blood and immune conditions. For investors watching NasdaqGS:INCY, this latest approval sits at the heart of the company’s core focus in hematology and oncology. Jakafi has...

MSA Safety (MSA) has just opened Q1 2026 earnings season with a run of solid headline figures, capped by Q4 2025 revenue of US$510.9 million and basic EPS of US$2.22. Over recent quarters the company has seen revenue move from US$499.7 million in Q4 2024 to US$421.3 million in Q1 2025 and then back to US$510.9 million in Q4 2025, while quarterly EPS ranged between roughly US$1.51 and US$2.23, setting up a results story where margins and profit quality are front and center for investors. See...

Event overview and why it matters for Westamerica Bancorporation (WABC) Westamerica Bancorporation (WABC) has expanded its share repurchase authorization to 4,000,000 shares and lifted its quarterly dividend to $0.48, indicating a focus on returning cash to shareholders. See our latest analysis for Westamerica Bancorporation. At a share price of $54.75, Westamerica Bancorporation has a 30 day share price return of 5.63% and a year to date share price return of 14.47%, alongside a 3 year total...

If you have been wondering whether PG&E at US$16.33 is priced attractively or not, the key question is how that share price lines up against the company’s underlying value. The stock has been relatively steady over the last year with a 0.4% return year to date and a 3.3% decline over 12 months. Over the last 30 days it declined 8.1%, following a modest 0.4% gain over the past week. Recent news around PG&E has continued to focus on its role as a major California electric utility, including...

Suncrete (NasdaqGM:RMIX) has appointed Charles Owens and Noreen Skelly as independent directors to its Board. Both Owens and Skelly have also joined the Audit Committee, with Skelly serving as Chair. The appointments expand the Board and Audit Committee with additional construction and banking sector expertise. Suncrete, trading at around $15.4, has seen its share price move 38.9% over the past 30 days and 35.1% year to date, with a 39.1% return over the past year and a 2.7% decline over...

Emerging discounting on core On Holding products at key retailers and outlets has raised fresh questions about the strength of the NYSE:ONON premium brand. Channel checks highlight margin pressure in the wholesale channel, challenging recent messaging around full price discipline and margin expansion. The news follows the return of the co founders as co CEOs and arrives as investors reassess growth and profitability expectations. On Holding, trading at $34.59 under ticker NYSE:ONON, is...

Tanger (SKT) opened Q1 2026 with total revenue of US$150.4 million and basic EPS of US$0.25, alongside Funds From Operations of US$70.4 million. These results put fresh numbers behind the recent share price of US$36.20. Over the past year, the company’s total revenue moved from US$137.8 million in Q1 2025 to US$150.4 million in Q1 2026, while basic EPS shifted from US$0.17 to US$0.25. This places the latest quarter within a period described by management as one of expanding profitability and...

Investors may be wondering if First American Financial at around US$68 per share still offers value, or if most of the easy gains are already on the table. The stock is up 17.4% over the last 30 days and 12.0% year to date, with a 15.6% return over the past year and a 31.1% return over three years. These changes can influence how the market is pricing its risks and opportunities. These moves are playing out against a backdrop of ongoing interest in US insurance stocks and property related...

Q1 2026 earnings snapshot DigitalOcean Holdings (DOCN) opened Q1 2026 with trailing 12 month revenue of US$901.4 million and Basic EPS of US$2.83, backed by a trailing net income of US$259.3 million and a reported 206.8% earnings increase over the past year. Over recent quarters, the company has seen revenue move from US$204.9 million in Q4 2024 to US$242.4 million in Q4 2025, while quarterly Basic EPS has ranged from US$0.20 to US$1.74, creating a period where reported margins and profit...

If you are wondering whether Webull's current share price still leaves room for value or if most of the opportunity is already reflected in the stock, this article breaks down what the numbers indicate. Webull closed at US$7.33 most recently, with a 3.2% return over the last 7 days, a 52.1% return over 30 days, a 10.5% decline year to date, and a 50.9% decline over the past year. Those moves have come as Webull continues to attract attention from investors who watch trading platforms closely...

CNH Industrial (NYSE:CNH) is in active labor negotiations with nearly 300 UAW workers at its Racine, Wisconsin plant as their contract expires. The discussions follow a previous extended strike at the facility and there is currently no strike action in place. The talks are taking place while the company reports weak Q1 results, margin pressure, and historically low North American agricultural equipment demand. Management has reaffirmed its 2026 guidance, but labor uncertainty at Racine could...

Investors may be wondering whether International Paper is now priced attractively after a rough patch, or if the stock price still does not reflect its underlying value. The share price closed at US$31.86 with returns of a 6.3% decline over 7 days, an 8.4% decline over 30 days, a 20.8% decline year to date and a 25.3% decline over the last year, compared with a 13.5% gain over 3 years and a 33.4% decline over 5 years. Recent headlines around International Paper have focused on broad sector...

Madrigal Pharmaceuticals (NasdaqGS:MDGL) has secured an exclusive worldwide license to ARO-PNPLA3, an RNAi therapy for MASH, from Arrowhead Pharmaceuticals. The program is in clinical development, with Phase 1 data indicating substantial liver fat reduction and a favorable safety profile in a genetically defined MASH population. The deal expands Madrigal's pipeline beyond Rezdiffra and adds a precision medicine angle to its MASH franchise. Madrigal Pharmaceuticals enters this agreement with...

This article examines whether Vestis is attractively priced or already fully valued and walks through key signals that can help frame the stock's current valuation. Vestis recently closed at US$9.27, with returns of 18.4% over 30 days and 40.9% year to date. Meanwhile, the 7 day return of 3.6% and 1 year return of 6.4% indicate that the stock has not moved in a straight line. Recent headlines around Vestis have focused on its position within the Commercial Services sector and how investors...

Crescent Energy (CRGY) has just opened 2026 with a volume focused Q1 update, with trailing twelve month revenue of US$3.6b and basic EPS of US$0.55 capped by Q4 2025 revenue of US$865 million alongside a small basic EPS loss of about US$0.03. Over the past year, revenue has moved from US$2.9b in 2024 to US$3.6b for the trailing twelve months, while basic EPS has shifted from a loss of about US$0.88 to a gain of roughly US$0.55, setting the backdrop for a business now reporting profit on a...

If you are wondering whether Progyny's current share price really reflects its potential or if the stock is just out of favour, this article breaks down what the numbers say about value. At a last close of US$18.98, the stock has returned 3.3% over the past week and 14.3% over the last month, but is still showing a 26.3% decline year to date and an 18.8% decline over 1 year. Recent headlines around Progyny have focused on broader sentiment toward healthcare benefits providers and changing...

Leonardo DRS Q1 2026 Earnings Snapshot Leonardo DRS (DRS) comes into its latest Q1 2026 update following Q4 2025 revenue of US$1.06 billion, Basic EPS of US$0.39 and net income of US$102 million, with trailing twelve month revenue at US$3.6 billion and Basic EPS of about US$1.05. The company reported quarterly revenue increasing from US$799 million in Q1 2025 to US$1.06 billion in Q4 2025, while Basic EPS over the same period moved from US$0.19 to US$0.39. This sets up the new quarter against...

If you are wondering whether T-Mobile US at around US$194 per share still offers value, the key is understanding what the current price actually reflects. The stock is down 1.9% over the last week, 2.2% over the past month, 2.6% year to date and 21.3% over the last year, even though the 3 year and 5 year returns sit at 42.3% and 47.9% respectively. Recent attention on T-Mobile US has centered on its position in the US telecom market, including ongoing competition in mobile plans and...

Embecta (EMBC) opened 2026 with Q1 revenue of US$261.2 million and basic EPS of US$0.75, alongside trailing twelve month revenue of about US$1.1 billion and EPS of US$2.38. These figures sit against trailing earnings growth of 139.7% and revenue growth of 0.8% year over year. Over recent quarters the company has seen revenue move between US$259 million and US$295.5 million, while quarterly basic EPS has ranged from US$0.25 to US$0.78. Together this sets up a picture of improving net profit...

If you are wondering whether Emerson Electric at around US$138 per share still offers value, it helps to step back and look at what the recent share price is actually telling you. The stock has been relatively steady over the last week, while posting returns of 5.1% over 30 days, 1.9% year to date and 31.1% over the past year, with longer term returns of 75.1% over three years and 60.8% over five years. Recent coverage has focused more on Emerson Electric's positioning within industrial...